The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.73
Bid: 9.74
Ask: 10.20
Change: -0.04 (-0.41%)
Spread: 0.46 (4.723%)
Open: 9.73
High: 9.73
Low: 9.73
Prev. Close: 9.77
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AT1 Issuance for a total nominal amount

9 Nov 2017 07:00

RNS Number : 9890V
Banco Bilbao Vizcaya Argentaria SA
08 November 2017
 

 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, and further to the relevant information dated 7th November 2017, hereby proceeds to notify the following:

 

 

RELEVANT INFORMATION

 

 

 

BBVA has agreed to carry out an issue of preferred securities contingently convertible into newly issued ordinary shares of BBVA with exclusion of pre-emptive subscription rights for shareholders (the "Securities") for a total nominal amount of 1,000,000,000 US Dollars (the "Issuance").

 

The remuneration of the Securities, whose payment is subject to certain conditions and to the discretion of the Bank, has been set at 6.125% on an annual basis for the first ten years. After that, it will be reviewed in accordance with the applicable terms and conditions of the Issuance by applying a margin of 387 basis points on the 5-year Mid-Swap Rate.

 

BBVA will request that the Securities qualify as Additional Tier 1 Capital pursuant to Law 10/2014, of 26 June, on regulation, supervision and solvency of credit entities and Regulation (EU) No. 575/2013 of the European Parliament and of the Council of 26 June 2013, on prudential requirements for credit institutions and investment firms.

 

The Securities shall not be offered, distributed or sold in Spain or to Spanish tax residents, without prejudice to the additional sales restrictions set out in the terms and conditions of the Issuance.

 

BBVA will request the listing of the Securities on the Global Exchange Market of the Irish Stock Exchange plc.

 

Furthermore, BBVA informs that, for the purposes set out in articles 414, 417 and 511 of the Corporate Enterprises Act, the director's report and the report of the independent expert/auditor of accounts different from BBVA's auditor, both related to the Issuance, have been issued. These reports will be available to shareholders through their publication on BBVA's website (www.bbva.com) on the Issuance closing date (expected to take place on 16th November 2017) and will be reported to the first General Shareholders' Meeting to be held after the Issuance.

 

 

 

Madrid, 8 November 2017

 

 

 

Important information:

There are restrictions with respect to the offering of the Securities in various jurisdictions, including the United Kingdom, Spain, Japan, Singapore, Hong Kong, Canada, Switzerland and the European Economic Area.

This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

This document is not a prospectus and is not an offer or a solicitation to buy, sell, subscribe or exchange any securities issued or to be issued by BBVA. No such offer in relation to the Securities shall be conducted in any jurisdiction in which said offer is not made in conformity with the applicable legislation.

This document is not an offer for sale of securities in the United States and the Securities may not be offered or sold in the United States nor to, on behalf or for the benefit of, any citizen of the United States, as defined in the Regulation S of the US Securities Act of 1933, as amended ("US Securities Act"), unless such Issuance is registered or falls under an exception of registration pursuant the US Securities Act.

In relation with the Issuance, BBVA has filed a registration statement (including a prospectus), and a prospectus supplement with the US Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents BBVA has filed with the SEC for more complete information about BBVA and the Issuance. You may obtain these documents for free by visiting the SEC web site at www.sec.gov.

This announcement is not a prospectus but rather is an announcement, and investors should not subscribe for any Securities except on the basis of the information contained in the prospectus, the prospectus supplement and the other documents filed by BBVA with the SEC that are incorporated by reference in the registration statement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFFPESXXFAF
Date   Source Headline
16th Mar 20217:36 amRNS2021 AGM Proposed Resolutions
16th Mar 20217:00 amRNSCash payment against share premium acc. calendar
15th Mar 20216:06 pmRNS2021 Annual General Meeting Call
12th Mar 20215:01 pmRNSBasel Accord Pillar III 2020
3rd Mar 20215:07 pmRNSEarly redemption of preferred securities
29th Jan 20217:00 amRNS4Q20 Quarterly Report
29th Jan 20217:00 amRNS4Q20 Results Press Release
29th Jan 20217:00 amRNS4Q20 Results Report
29th Jan 20217:00 amRNSShareholders' Remuneration
25th Jan 20217:00 amRNS2021 BBVA has completed the sale of BBVA Paraguay
20th Jan 20215:08 pmRNS4Q20 Results Presentation Announcement
14th Dec 20205:21 pmRNSAgreement with Allianz
27th Nov 20207:00 amRNSEnd of conversations with Banco de Sabadell
16th Nov 20205:13 pmRNSConversations with Banco de Sabadell, S.A.
16th Nov 20207:00 amRNSPresentation_Sale of BBVA's U.S. subsidiary to PNC
16th Nov 20207:00 amRNSSale of BBVA's U.S. subsidiary to PNC
30th Oct 20207:21 amRNS3Q20 Results Presentation
30th Oct 20207:09 amRNS3Q20 Quarterly Report
30th Oct 20207:05 amRNS3Q20 Results Press Release
21st Oct 20205:06 pmRNS3Q20 Results Presentation Announcement
23rd Sep 20207:48 amRNSBBVA CEO Presentation
14th Aug 20209:00 amRNSPost-Stab Notice BBVA GBP 300m
30th Jul 20207:00 amRNS2Q20 Results Presentation
30th Jul 20207:00 amRNS2Q20 Results Report
30th Jul 20207:00 amRNS2Q20 Results Press Release
21st Jul 20204:57 pmRNS2Q20 Results Presentation Announcement
14th Jul 202012:12 pmRNSPre-Stab Notice BBVA GBP 300m due 15th July
7th Jul 20205:20 pmRNSOffer of securities convertible into shares_2
7th Jul 20208:23 amRNSOffer of securities convertible into shares
3rd Jul 202010:34 amRNSPost-stab Notice BBVA EUR 1bn
23rd Jun 20207:00 amRNSFitch Rating Update
27th May 20205:41 pmRNSPre-Stab Notice BBVA EUR 1BN due 4th June 2020
30th Apr 20207:28 amRNS1Q20 Results Press Release
30th Apr 20207:05 amRNSNew Composition BD Committees
30th Apr 20207:05 amRNS1Q20 Results Report
30th Apr 20207:00 amRNS1Q20 Results Presentation
30th Apr 20207:00 amRNSDividend Policy
28th Apr 20207:00 amRNSAgreement between BBVA and Allianz
21st Apr 20205:00 pmRNS1Q20 Results Presentation Announcement
9th Apr 20208:21 amRNSPotential Note Purchase
16th Mar 20207:00 amRNSPrudential Relevance Report (Pillar III) 2019
13th Mar 20203:12 pmRNSResolutions adopted by the AGM 2020
10th Mar 20205:30 pmRNSBBVA Statement to Shareholders 2020 AGM
12th Feb 20208:50 amRNS2020 AGM Proposed Resolutions
11th Feb 20207:00 amRNSFinal dividend calendar 2019
10th Feb 20205:33 pmRNS2020 AnnualGeneral Meeting Call
5th Feb 20204:26 pmRNSPost Stabilisation Notice - BBVA S.A.
31st Jan 20207:28 amRNS4Q19 Results Presentation
31st Jan 20207:25 amRNS4Q19 Results Press Release
31st Jan 20207:21 amRNS4Q19 Results Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.